Navigation Links
MedQuist Reports Third Quarter 2008 Results
Date:11/4/2008

MOUNT LAUREL, N.J., Nov. 4 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ), the largest Medical Transcription Service Organization (MTSO) in the world, today announced its results for the quarter ended September 30, 2008.

Net revenues for the third quarter of 2008 were $81.3 million compared with $82.5 million in the third quarter of 2007. The decrease in net revenues of $1.2 million or 1% from the prior year period was driven primarily by lower average pricing.

The operating loss for the quarter improved to a loss of $5.3 million compared to an operating loss of $10.3 million in the third quarter of 2007. The current period operating loss includes a charge of $5.9 million related to a tentative settlement of the Department of Justice's (DOJ) investigation of the company. The DOJ and the company have reached a tentative agreement to settle the DOJ's civil investigation for a payment of $6.8 million of which $0.9 million was previously recorded. Non-GAAP operating income (excluding the cost of investigation and legal proceedings, net) improved by $7.8 million to a profit of $1.9 million in the third quarter of 2008 compared to a non-GAAP operating loss of $5.9 million in the third quarter of 2007.

Cost of revenues were reduced by $7.1 million or 11% to $57.2 million in the third quarter of 2008 compared to $64.3 million in the third quarter of 2007. This resulted in a decrease in cost of revenues as a percentage of net revenues to 70% compared to 78% in the third quarter of 2007.

Selling general and administrative expenses declined $2.4 million or 15% to $13.1 million in the third quarter of 2008 compared to $15.5 million in the third quarter of 2007. This decline primarily reflects the benefits of the re
'/>"/>

SOURCE MedQuist Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. MedQuist Reports Second Quarter 2008 Results
2. MedQuist Announces Changes to Board of Directors
3. MedQuist Announces Declaration of $2.75 per share Dividend on Common Stock
4. Award-Winning Massachusetts Hospital Selects MedQuist Enterprise Technology for Clinical Documentation and Speech Recognition
5. MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO
6. MedQuist to Get New Majority Stakeholder
7. MedQuist Technology Solutions to Power Documentation Workflow at New England Facility
8. MedQuist Announces Entry Into Settlement Term Sheet Resolving South Broward Litigation
9. Leading Arizona Radiological Group Selects MedQuist for Speech Recognition Solution
10. MedQuist Announces Appointment of Brian ODonoghue and Mark E. Schwarz to its Board of Directors
11. MedQuist Files Preliminary Proxy Statement and Applies for Listing on NASDAQ
Post Your Comments:
*Name:
*Comment:
*Email: